The first three partnerships (Medtronics, Biomet, and Smith and Nephew) to my understanding did not have automatic use it or lose it provisions. On the other hand, contracts with the first two have already been terminated. The company must still hold out some hope for Smith and Nephew.
Ann: Appendix 3B Leon Hoare, page-19
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.06 |
Change
0.000(0.00%) |
Mkt cap ! $1.422B | |||
| Open | High | Low | Value | Volume |
| $2.07 | $2.08 | $2.04 | $1.857M | 901.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 11510 | $2.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.07 | 76972 | 9 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |